ACTIVE

GSK INVESTMENT COMPANY

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

25,3 k €

-92.1% YoY

Gross margin

221,8 k €

-19.1% YoY

Equity

104,9 k €

-89.3% YoY

What does GSK INVESTMENT COMPANY do?

GSK INVESTMENT COMPANY is a Private limited company incorporated in 2006. Its registered office is in Hasselt.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0883.242.111

Incorporation

31/08/2006

Legal form

Private limited company

Registered office

Guffenslaan 44
3500 Hasselt · FlandreSee on map

Contributed capital

79 624,86 €

Latest accounts

31/12/2025

Signals

ProfitablePositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Gross margin	221,8 k €	-19.1%	274,3 k €	+16.9%	234,6 k €	+29.9%	180,6 k €	-35.4%	279,6 k €	-87.7%	2,3 M €	+488%	386,5 k €	+508%	63,6 k €	-11.2%	71,6 k €	-40.3%	120 k €	+466%	21,2 k €	-2.5%	21,7 k €	+19.4%	18,2 k €	-60.5%	46,1 k €	+243%	13,4 k €	+118%	6,2 k €	-17.9%	7,5 k €	-83.0%	44,1 k €	-27.9%	61,2 k €
EBITDA	213,1 k €	-4.9%	223,9 k €	+3.1%	217,2 k €	+20.9%	179,7 k €	-33.5%	270,1 k €	+167%	101,4 k €	-73.6%	383,9 k €	+537%	60,3 k €	-10.7%	67,5 k €	-36.8%	106,8 k €	+487%	18,2 k €	-6.2%	19,4 k €	+16.6%	16,6 k €	-62.7%	44,6 k €	+244%	13 k €	+123%	5,8 k €	-18.0%	7,1 k €	+30.8%	5,4 k €	-58.1%	13 k €
Operating result	126,6 k €	-9.1%	139,2 k €	-15.6%	164,9 k €	+39.6%	118,1 k €	-42.8%	206,5 k €	+182%	73,1 k €	-79.4%	355,6 k €	+1009%	32,1 k €	-2.1%	32,7 k €	-54.6%	72,1 k €	+27168%	-266,2 €	-129%	927,8 €	-64.5%	2,6 k €	-92.2%	33,3 k €	+195%	11,3 k €	+102%	5,6 k €	-15.6%	6,6 k €	+33.9%	4,9 k €	-59.6%	12,2 k €
Net result	25,3 k €	-92.1%	318,3 k €	+222%	99 k €	+83.5%	53,9 k €	-66.4%	160,5 k €	+123%	72 k €	-77.0%	313,5 k €	+957%	-36,6 k €	+32.5%	-54,2 k €	-10401%	526,2 €	+101%	-56,7 k €	+28.8%	-79,7 k €	-341%	-18,1 k €	-291%	9,5 k €	+94.4%	4,9 k €	-14.4%	5,7 k €	-4.1%	5,9 k €	+54.0%	3,8 k €	-67.0%	11,7 k €
Balance sheet
Equity	104,9 k €	-89.3%	979,6 k €	+35.8%	721,3 k €	-3.3%	746,1 k €	+7.8%	692,2 k €	+25.7%	550,7 k €	+15.0%	478,7 k €	+190%	165,2 k €	-18.1%	201,8 k €	-21.2%	256 k €	+0.2%	255,5 k €	-18.2%	312,2 k €	-20.3%	392 k €	-87.4%	3,1 M €	+0.0%	3,1 M €	+0.0%	3,1 M €	+15094%	20,5 k €	+0.6%	20,3 k €	+0.2%	20,3 k €
Total assets	2,6 M €	-3.7%	2,7 M €	+0.2%	2,7 M €	-6.7%	2,9 M €	+12.6%	2,6 M €	-15.5%	3 M €	-39.1%	5 M €	+13.3%	4,4 M €	+5.2%	4,2 M €	-1.9%	4,3 M €	-0.7%	4,3 M €	+11.4%	3,8 M €	+2.6%	3,7 M €	+2.9%	3,6 M €	+1.5%	3,6 M €	+15.2%	3,1 M €	+10582%	29,2 k €	+20.8%	24,1 k €	-42.8%	42,2 k €
Cash	20,8 k €	-54.3%	45,6 k €	-34.3%	69,4 k €	+816%	7,6 k €	-48.4%	14,7 k €	-21.6%	18,7 k €	+1857%	957,6 €	-95.0%	19,1 k €	+1003%	1,7 k €	-92.3%	22,6 k €	+1044%	2 k €	+370%	419,9 €	-83.6%	2,6 k €	-91.9%	31,7 k €	+2200%	1,4 k €	-64.0%	3,8 k €	-86.7%	28,9 k €	+28.4%	22,5 k €	-44.8%	40,8 k €
Debts	2,5 M €	+47.7%	1,7 M €	-12.8%	1,9 M €	-8.0%	2,1 M €	+13.6%	1,8 M €	-24.5%	2,4 M €	-44.7%	4,4 M €	+6.0%	4,2 M €	+6.6%	3,9 M €	-0.6%	3,9 M €	-0.9%	4 M €	+15.0%	3,5 M €	+3.5%	3,3 M €	+546%	516,8 k €	+9.5%	471,8 k €	+8760%	5,3 k €	-38.7%	8,7 k €	+129%	3,8 k €	-82.6%	21,9 k €
Other
Workforce	–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		0,7 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 5 ended

Active mandates

GSK-Beheer

Director · 0871.717.917

Represented by Gerard Schouten

Active

Ended mandates

Gerard Schouten

Manager

Ended

GSK-Beheer

Manager · 0871.717.917

Represented by Gerard Schouten

Ended

GSK-Beheer

Mandate · 0871.717.917

Ended

GSK-Beheer

Administrator - manager · 0871.717.917

Represented by Gerard Schouten

Ended

At this address

Other companies at this address

Company	CBE no.
BOUWID● Active	0833.021.152
BRIC architectuur● Active	1014.907.040
GSK-Beheer● Active	0871.717.917
GSK-PROJECTEN● Active	0890.187.608
TERRA NOVA● Active	1035.421.748

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/06/2026	07/07/2025	28/06/2024	10/07/2023	20/07/2022	20/07/2021
General meeting	25/06/2026	26/06/2025	27/06/2024	29/06/2023	23/06/2022	24/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	25/06/2026	29/06/2026	Dutch	PDF
Abridged model	31/12/2024	26/06/2025	07/07/2025	Dutch	PDF
Abridged model	31/12/2023	27/06/2024	28/06/2024	Dutch	PDF
Abridged model	31/12/2022	29/06/2023	10/07/2023	Dutch	PDF
Abridged model	31/12/2021	23/06/2022	20/07/2022	Dutch	PDF
Abridged model	31/12/2020	24/06/2021	20/07/2021	Dutch	PDF
Abridged model	31/12/2019	25/06/2020	12/07/2020	Dutch	PDF
Abridged model	31/12/2018	27/06/2019	08/07/2019	Dutch	PDF
Abridged model	31/12/2017	28/06/2018	29/06/2018	Dutch	PDF
Abridged model	31/12/2016	29/06/2017	19/07/2017	Dutch	PDF
Abridged model	31/12/2015	30/06/2016	25/07/2016	Dutch	PDF
Abridged model	31/12/2014	25/06/2015	29/06/2015	Dutch	PDF
Abridged model	31/12/2013	26/06/2014	18/07/2014	Dutch	PDF
Abridged model	31/12/2012	27/06/2013	11/07/2013	Dutch	PDF
Abridged model	31/12/2011	28/06/2012	29/06/2012	Dutch	PDF
Abridged model	31/12/2010	29/06/2011	30/06/2011	Dutch	PDF
Abridged model	31/12/2009	24/06/2010	28/06/2010	Dutch	PDF
Abridged model	31/12/2008	25/06/2009	06/07/2009	Dutch	PDF
Abridged model	31/12/2007	26/06/2008	04/07/2008	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 5 ended

Active mandates

GSK-Beheer

Director · 0871.717.917

Represented by Gerard Schouten

Active

Ended mandates

Gerard Schouten

Manager

Ended

GSK-Beheer

Manager · 0871.717.917

Represented by Gerard Schouten

Ended

GSK-Beheer

Mandate · 0871.717.917

Ended

GSK-Beheer

Administrator - manager · 0871.717.917

Represented by Gerard Schouten

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates06/08/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates12/03/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Registered office19/02/2016
MAATSCHAPPELIJKE ZETEL
PDF
Capital / shares04/09/2013
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Capital / shares22/07/2010
BENAMING - KAPITAAL - AANDELEN
PDF
Mandates26/03/2010
MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Other17/03/2008
BENAMING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Other08/09/2006
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202525,3 k €↓
2024
Annual accounts 2024318,3 k €↑
2023
Annual accounts 202399 k €↑
2022
Annual accounts 202253,9 k €↓
2021
Annual accounts 2021160,5 k €↑
2020
Annual accounts 202072 k €↓
2019
Annual accounts 2019313,5 k €↑
2018
Annual accounts 2018-36,6 k €↑
2017
Annual accounts 2017-54,2 k €↓
2016
Annual accounts 2016526,2 €↑
2015
Annual accounts 2015-56,7 k €↑
2014
Annual accounts 2014-79,7 k €↓
2013
Annual accounts 2013-18,1 k €↓
2012
Annual accounts 20129,5 k €↑
2011
Annual accounts 20114,9 k €↓
2010
Annual accounts 20105,7 k €↓
2009
Annual accounts 20095,9 k €↑
2009
Name changeGsk Investment Company
2008
Annual accounts 20083,8 k €↓
2007
Annual accounts 200711,7 k €
2007
Name changePRS
31/08/2006
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

GSK INVESTMENT COMPANY

Overview

What does GSK INVESTMENT COMPANY do?

Trend over 19 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline